Custom service
Peptide N-Terminal Modification
Modify the n-terminus with acyl groups, labels, spacers or cyclization handles
The service is built around N-acylation and carbamate caps. Depending on the molecule we may move to N-terminal label and linker installation or native chemical ligation handles to improve stability, loading or yield, and every batch is released with modified peptide with N-terminal confirmation by MS/MS.
Because Peptide N-Terminal Modification projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Half-life and stability tuning through N-capping
N-terminal attachment points for conjugation
N-terminal modifications requiring licensed proprietary caps
Modifications requiring radiological or BSL-3 containment
Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.
Service Highlights
- N-acylation and carbamate caps as the default route, with N-terminal label and linker installation held as a proven fallback
- Native chemical ligation handles worked into the design where the application requires it
- Modification sites are mapped on the sequence and confirmed by MS/MS before release
- Analytical confirmation of every intermediate before the final release
- Modified and unmodified species are separated and quantified, not just reported
- Modified peptide with N-terminal confirmation by MS/MS delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence & modification map
We annotate every modification site, protection strategy and analytical target before synthesis starts.
Solid-phase assembly
The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.
Modification chemistry
Post-synthesis steps — N-acylation and carbamate caps, N-terminal label and linker installation — are run under conditions validated on a test cleavage.
Cleavage & purification
Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.
Analytical release
Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.
Documentation
Modified peptide with N-terminal confirmation by MS/MS is released with the batch record and analytical package after QC sign-off.
Specifications & timeline
- Turnaround
- 2–4 weeks
- Typical scale
- 0.5 mg – 1 g modified peptide
- Chemistry options
- N-acylation and carbamate caps; N-terminal label and linker installation; native chemical ligation handles
- Deliverable
- Modified peptide with N-terminal confirmation by MS/MS
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
- Shipping
- Ambient or blue ice as stability data dictate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.